Drugs / Fluarix-AS50
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00318149 | Oct 2005 → May 2006 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluarix-AS50 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00318149 ↗ |
| Modality | Vaccine | “four different adjuvanted GlaxoSmithKline influenza vaccines” NCT00318149 ↗ |
| Route | Intramuscular | “administered intramuscularly” NCT00318149 ↗ |